ResearcherMayo ClinicNo recent work listed
Federico Innocenti
Matched on ORCID iD 0000-0001-9247-979X; OpenAlex author ID A5045774368. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2012: 2 papers · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper
Papers 6
- An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance). Co-author DOI 10.1097/fpc.0000000000000375↗
- The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. Co-author DOI 10.1371/journal.pone.0202272↗
- Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
- 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). Co-author DOI 10.1093/jnci/dju185↗
- A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Co-author DOI 10.1158/1078-0432.ccr-11-1387↗
- Systemic therapies for pancreatic cancer--the role of pharmacogenetics. Last author DOI 10.2174/138945012800564068↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kouros Owzar · 4 shared papers, 2012–2019 · strength 0.20
- Paper An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 … DOI 10.1097/fpc.0000000000000375↗
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Chen Jiang · 4 shared papers, 2012–2019 · strength 0.20
- Paper An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 … DOI 10.1097/fpc.0000000000000375↗
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Hedy Lee Kindler · 4 shared papers, 2012–2019 · strength 0.20
- Paper An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 … DOI 10.1097/fpc.0000000000000375↗
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Mark J. Ratain · 3 shared papers, 2012–2019 · strength 0.16
- Paper An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 … DOI 10.1097/fpc.0000000000000375↗
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 803… DOI 10.1158/1078-0432.ccr-11-1387↗
- Herbert I. Hurwitz · 2 shared papers, 2012–2019 · strength 0.10
- Paper An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 … DOI 10.1097/fpc.0000000000000375↗
- Paper A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 803… DOI 10.1158/1078-0432.ccr-11-1387↗
- Katherine Van Loon · 2 shared papers, 2014–2018 · strength 0.10
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Alan Paul Venook · 2 shared papers, 2014–2018 · strength 0.10
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Yusuke Nakamura · 2 shared papers, 2012–2018 · strength 0.08
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 803… DOI 10.1158/1078-0432.ccr-11-1387↗
- Andrew B. Nixon · 1 shared paper, 2019 · strength 0.08
- Nicole F. Neel · 1 shared paper, 2018 · strength 0.06
- Marina Talamonti · 1 shared paper, 2018 · strength 0.06
- David J. Bentrem · 1 shared paper, 2018 · strength 0.06
- Jen Jen Yeh · 1 shared paper, 2018 · strength 0.06
- Gloria M. Petersen · 1 shared paper, 2018 · strength 0.06
- Robert R. McWilliams · 1 shared paper, 2018 · strength 0.06
- Ross Andrew Soo · 1 shared paper, 2012 · strength 0.05
- Eileen Mary O'Reilly · 1 shared paper, 2014 · strength 0.04
- Charles S. Fuchs · 1 shared paper, 2014 · strength 0.04
- Mary F. Mulcahy · 1 shared paper, 2014 · strength 0.04
- Liewei Wang · 1 shared paper, 2012 · strength 0.02
- Richard M. Goldberg · 1 shared paper, 2012 · strength 0.02
- Liang Li · 1 shared paper, 2012 · strength 0.02
- Hitoshi Zembutsu · 1 shared paper, 2012 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.